BeyondSpring Inc.
BYSI$69M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaFLORHAM PARK
Drugs in Pipeline
3
Phase 3 Programs
3
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
BYSI News
Catalyst Timeline
0 upcoming, 1 past
No catalysts found.
Drug Pipeline
Docetaxel + Plinabulin (DP)
Non-Small Cell Lung Cancer
Plinabulin
Chemotherapy-induced Neutropenia
Pegfilgrastim
Chemotherapy-induced Neutropenia
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Docetaxel + Plinabulin (DP) | Phase 3 | Non-Small Cell Lung Cancer | - | - |
Plinabulin | Phase 3 | Chemotherapy-induced Neutropenia | - | - |
Pegfilgrastim | Phase 3 | Chemotherapy-induced Neutropenia | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply